NCT00859105
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis
Phase: Phase 3
Role: Lead Sponsor
Start: Feb 29, 2008
Completion: Not specified